ClinVar Miner

Submissions for variant NM_001371279.1(REEP1):c.792T>G (p.Pro264=)

dbSNP: rs2103944449
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001995049 SCV002256484 uncertain significance Hereditary spastic paraplegia 31 2021-03-22 criteria provided, single submitter clinical testing Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This sequence change disrupts the translational stop signal of the REEP1 mRNA. It is expected to extend the length of the REEP1 protein by 54 additional amino acid residues. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with REEP1-related conditions. This variant results in an extension of the REEP1 protein. Other variant(s) that result in a similarly extended protein product (p.*202Trpext*54) have been observed in individuals with REEP1-related conditions (PMID: 29124833). This suggests that these extensions may be clinically significant. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.